Detalhe da pesquisa
1.
Disrupting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapy.
bioRxiv;
2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38405985
2.
Leukemia-intrinsic determinants of CAR-T response revealed by iterative in vivo genome-wide CRISPR screening.
Nat Commun;
14(1): 8048, 2023 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38052854
3.
ATR inhibition induces synthetic lethality in mismatch repair-deficient cells and augments immunotherapy.
Genes Dev;
37(19-20): 929-943, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37932012
4.
Protocol for in vivo CRISPR screening using selective CRISPR antigen removal lentiviral vectors.
STAR Protoc;
4(1): 102082, 2023 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36861834
5.
In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer.
Nat Immunol;
23(10): 1495-1506, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36151395
6.
PI3K activation allows immune evasion by promoting an inhibitory myeloid tumor microenvironment.
J Immunother Cancer;
10(3)2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35264433
7.
Extracellular matrix proteins regulate NK cell function in peripheral tissues.
Sci Adv;
8(11): eabk3327, 2022 03 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35294229
8.
Checkpoint blockade-induced CD8+ T cell differentiation in head and neck cancer responders.
J Immunother Cancer;
10(1)2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35058328
9.
Mutant IDH Inhibits IFNγ-TET2 Signaling to Promote Immunoevasion and Tumor Maintenance in Cholangiocarcinoma.
Cancer Discov;
12(3): 812-835, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34848557
10.
Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity.
Nature;
595(7866): 309-314, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33953401
11.
In vivo screens using a selective CRISPR antigen removal lentiviral vector system reveal immune dependencies in renal cell carcinoma.
Immunity;
54(3): 571-585.e6, 2021 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33497609
12.
Functional Genomics Identifies Metabolic Vulnerabilities in Pancreatic Cancer.
Cell Metab;
33(1): 199-210.e8, 2021 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33152323
13.
Tumor-Derived PGE2 Gives NK Cells a Headache.
Immunity;
53(6): 1131-1132, 2020 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33326763
14.
Author Correction: Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade.
Nat Immunol;
20(11): 1556, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31582823
15.
Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade.
Nat Immunol;
20(3): 326-336, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30778252
16.
Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade.
Nature;
565(7737): 43-48, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30559380
17.
Pooled in vivo screens for cancer immunotherapy target discovery.
Immunotherapy;
10(3): 167-170, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29370725
18.
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target.
Nature;
547(7664): 413-418, 2017 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28723893
19.
PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity.
J Exp Med;
214(4): 895-904, 2017 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28302645